Zylö Therapeutics

Zylö’s ‘Powered by Z-pod®’ Technology Featured in XXIV’s New Product Line Launch

Leslie BHA2025-08-27T12:25:42-04:00GREENVILLE, SC, UNITED STATES, August 20, 2025 /EINPresswire.com/ -- Zylö Therapeutics announced that its patented Z-pod® topical delivery platform has been incorporated into the initial launch of skincare brand XXIV’s new line, twentyfour. The debut includes two products formulated with Y100™-loaded Z-pods®: ⦁ StepZero™ — a topical powder designed for extended age-reversal ⦁ HYDRÍQ™ — a hydrator formulated for extended hydration and age-reversal "We are pleased to see our Z-pod® technology incorporated into XXIV’s product launch. Independent studies suggest this platform can extend...

Zylö’s ‘Powered by Z-pod’ technology named twice as a finalist in the prestigious C&T Allē Awards

Antonette Ho2024-11-29T16:57:18-05:00Zylö’s patented Z-pod® topical delivery platform was recently named as a 2025 Cosmetic & Toiletries (C&T) Allē Awards finalist in two categories: (i) Anti-Aging Ingredient Blend and (ii) Color, Sun & Nutricosmetic Ingredient Blend. C&T magazine—which is a leading resource for cosmetic scientists and R&D managers—received an all-time high number of entries, and according to C&T, “the competition was fierce.” Zylö’s finalist in the Anti-Aging Ingredient Blend category is YuvaBio® Y100™-loaded Z-pods, which combines Zylö’s Z-pod technology with YuvaBio’s breakthrough...

Eight nanotechnology companies to watch out for

Antonette Ho2024-10-26T09:29:18-04:00Nanotechnology, which is the manipulation of molecules on an atomic scale, has been implemented by companies in medicine, with numerous applications in drug discovery, tissue engineering, imaging, and diagnostics. As techniques and tools to exploit nanotechnology in the field of healthcare progress, here are eight nanotechnology companies that you should know about. Zylo Therapeutics - Specializing in drug delivery, American biotech Zylo Therapeutics has created Z-pods, which are amorphous silica particles that have been engineered to encapsulate compounds, and can...

Greenville-based Zylo Therapeutics creates spinoff company

Antonette Ho2024-04-30T03:07:16-04:00Greenville-based Zylö Therapeutics has created a spinoff company to market its trademarked Z-pod topical delivery platform in the pharmaceutical industry.Atticus Pharma Inc. is initially focused on the joint development agreement with Yuva Biosciences, where Atticus has the worldwide, exclusive rights to YuvaBio’s Y20, a terminalia chebula extract for the treatment of alopecia-related conditions and for wound-healing, according to a news release. The Z-pod delivery technology, licensed from Albert Einstein College of Medicine, is based on silica-derived particles — called Z-pods,...

Zylö Therapeutics founder, Bubble Paper of Williamston honored at SCRA Annual Summit

Antonette Ho2024-04-13T10:21:16-04:00South Carolina Research Authority, a public, nonprofit corporation that works to fuel the state’s innovation economy, honored Bubble Paper of Williamston and Scott Pancoast, founder and CEO of Zylö Therapeutics, at its Annual Summit April 10 in Columbia. Read more >>

Zylö’s ‘Powered by Z-pods®’ technology incorporated into BosleyMD’s new product line

Antonette Ho2024-02-10T18:14:13-05:00Zylö’s Z-pod® topical delivery platform is being used by BosleyMD—the Thinning Hair Authority™—as a key feature in their newly launched product line, Revive+ Densifying Foam. BosleyMD is currently offering a male version and a female version through CVS and online (see link below); distribution through Walmart and Ulta Beauty is expected soon. Cable TV and online advertising will be used to promote the products. Read more >>

Looking at the Life Sciences Industry in South Carolina

Antonette Ho2024-02-10T18:12:02-05:00In recent years, South Carolina has become a hub of sorts for the life sciences and biotech industries. The Palmetto State has more than 1,000 companies – large and small, established and startup – that are making an impact on the local community and the world at large. Integrated Media Publishing hosted a roundtable discussion with four of the leaders in the biotech world on Jan. 4, 2024. Q. The life sciences industry has been growing. The annual economic impact...

Zylö accepted into NYU’s exclusive Endless Frontier Labs mentorship program

Antonette Ho2023-10-06T00:19:21-04:00Zylö Therapeutics has been selected to join the Endless Frontier Labs (EFL) 2023-2024 cohort alongside 77 other startups. Over 1,400 companies applied, including over 350 life science companies, with only 26 chosen in each of the three tracks: life sciences, deep-tech, and digital tech. Over the next nine months, EFL mentors and NYU Stern MBA students will work with Zylö’s executive team to fine-tune Zylö strategies, craft an improved pitch deck, and set/achieve value-added objectives. Read more...

Zylö’s ‘Powered By Z-pod’ Technology Featured in Peer-Reviewed Paper Published in Experimental Dermatology

Antonette Ho2023-10-01T12:10:59-04:00The Z-pod® topical delivery platform was used in various in vivo studies that were highlighted in a peer-reviewed paper just published online by Experimental Dermatology titled, “Nano-encapsulated anandamide (AEA) reduces inflammatory cytokines in vitro and lesion severity in a murine model of cutaneous lupus erythematosus [CLE].” In these studies, AEA—a primary endocannabinoid that has been demonstrated to have anti-inflammatory and immunomodulatory effects—was loaded into Zylö’s proprietary Z-pod drug-delivery system. Read more >>